Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C23H24O4 |
| Molecular Weight | 364.4343 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(=O)OC1=CC=C(C=C1)C(=C2CCCCC2)C3=CC=C(OC(C)=O)C=C3
InChI
InChIKey=GVOUFPWUYJWQSK-UHFFFAOYSA-N
InChI=1S/C23H24O4/c1-16(24)26-21-12-8-19(9-13-21)23(18-6-4-3-5-7-18)20-10-14-22(15-11-20)27-17(2)25/h8-15H,3-7H2,1-2H3
| Molecular Formula | C23H24O4 |
| Molecular Weight | 364.4343 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: http://www.ncbi.nlm.nih.gov/pubmed/7097643Curator's Comment: description was created based on several sources, including, http://www.ncbi.nlm.nih.gov/pubmed/7097643
Sources: http://www.ncbi.nlm.nih.gov/pubmed/7097643
Curator's Comment: description was created based on several sources, including, http://www.ncbi.nlm.nih.gov/pubmed/7097643
Cyclofenil is a anti-estrogen drug developed for the treatment of female infertility and for induction of ovulation. Cyclofenil exerts its action by binding to estrogen receptor beta and demonstrates agonism or antagonism depending on tissues type. The drug was withdrawn from the market due to high risk of hepatotoxicity.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: Q92731|||O75584 Gene ID: 2100.0 Gene Symbol: ESR2 Target Organism: Homo sapiens (Human) Sources: http://www.ncbi.nlm.nih.gov/pubmed/16610793 |
9.4 nM [Kd] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Curative | SEXOVID Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Design, synthesis, and evaluation of cyclofenil derivatives for potential SPECT imaging agents. | 2010-05 |
|
| Characterization of the pharmacophore properties of novel selective estrogen receptor downregulators (SERDs). | 2010-04-22 |
|
| Monitoring a coordinated exchange process in a four-component biological interaction system: development of a time-resolved terbium-based one-donor/three-acceptor multicolor FRET system. | 2010-04-07 |
|
| Photocontrol of protein activity in cultured cells and zebrafish with one- and two-photon illumination. | 2010-03-22 |
|
| Terameprocol, a methylated derivative of nordihydroguaiaretic acid, inhibits production of prostaglandins and several key inflammatory cytokines and chemokines. | 2009-01-08 |
|
| Nonclassical SNAPFL analogue as a Cy5 resonance energy transfer partner. | 2008-11-06 |
|
| Synthesis and identification of hydroxylated metabolites of the anti-estrogenic agent cyclofenil. | 2008-07 |
|
| Synthesis of new carbon-11 labeled cyclofenil derivatives for PET imaging of breast cancer estrogen receptors. | 2008-04 |
|
| Fluorimetric determination of cyclofenil using photochemical derivatization. | 2008-02-15 |
|
| Elemental isomerism: a boron-nitrogen surrogate for a carbon-carbon double bond increases the chemical diversity of estrogen receptor ligands. | 2007-06 |
|
| Synthesis and biodistribution of fluorine-18-labeled fluorocyclofenils for imaging the estrogen receptor. | 2007-05 |
|
| Fluorine-substituted cyclofenil derivatives as estrogen receptor ligands: synthesis and structure-affinity relationship study of potential positron emission tomography agents for imaging estrogen receptors in breast cancer. | 2006-04-20 |
|
| Design and synthesis of functionalized cyclopentadienyl tricarbonylmetal complexes for technetium-94m PET imaging of estrogen receptors. | 2005-03-17 |
|
| Infertility and subfertility. | 2004-06 |
|
| Exploration of the bicyclo[3.3.1]nonane system as a template for the development of new ligands for the estrogen receptor. | 2003-12-15 |
|
| The inhibitory effects of flavonoids and antiestrogens on the Glut1 glucose transporter in human erythrocytes. | 2003-12-15 |
|
| Mass spectrometric analysis of cyclofenil and its metabolites in human urine. | 2002 |
|
| Efficacy of clomiphene citrate and cyclofenil for infertile women with normal ovulatory cycles. | 2001-08 |
|
| Follicular stimulation and ovarian cancer. | 1989-09-16 |
|
| [Comparative clinical studies on clomiphen, cyclofenil and epimestrol (author's transl)]. | 1977-06 |
Sample Use Guides
In Vivo Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/6424373
600 mg/daily
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:18:00 GMT 2025
by
admin
on
Mon Mar 31 18:18:00 GMT 2025
|
| Record UNII |
J468V64WZ1
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C481
Created by
admin on Mon Mar 31 18:18:00 GMT 2025 , Edited by admin on Mon Mar 31 18:18:00 GMT 2025
|
||
|
WHO-ATC |
G03GB01
Created by
admin on Mon Mar 31 18:18:00 GMT 2025 , Edited by admin on Mon Mar 31 18:18:00 GMT 2025
|
||
|
WHO-VATC |
QG03GB01
Created by
admin on Mon Mar 31 18:18:00 GMT 2025 , Edited by admin on Mon Mar 31 18:18:00 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C78030
Created by
admin on Mon Mar 31 18:18:00 GMT 2025 , Edited by admin on Mon Mar 31 18:18:00 GMT 2025
|
PRIMARY | |||
|
220-089-1
Created by
admin on Mon Mar 31 18:18:00 GMT 2025 , Edited by admin on Mon Mar 31 18:18:00 GMT 2025
|
PRIMARY | |||
|
86464
Created by
admin on Mon Mar 31 18:18:00 GMT 2025 , Edited by admin on Mon Mar 31 18:18:00 GMT 2025
|
PRIMARY | |||
|
m3983
Created by
admin on Mon Mar 31 18:18:00 GMT 2025 , Edited by admin on Mon Mar 31 18:18:00 GMT 2025
|
PRIMARY | Merck Index | ||
|
2983
Created by
admin on Mon Mar 31 18:18:00 GMT 2025 , Edited by admin on Mon Mar 31 18:18:00 GMT 2025
|
PRIMARY | RxNorm | ||
|
Cyclofenil
Created by
admin on Mon Mar 31 18:18:00 GMT 2025 , Edited by admin on Mon Mar 31 18:18:00 GMT 2025
|
PRIMARY | |||
|
753
Created by
admin on Mon Mar 31 18:18:00 GMT 2025 , Edited by admin on Mon Mar 31 18:18:00 GMT 2025
|
PRIMARY | |||
|
2624-43-3
Created by
admin on Mon Mar 31 18:18:00 GMT 2025 , Edited by admin on Mon Mar 31 18:18:00 GMT 2025
|
PRIMARY | |||
|
SUB06852MIG
Created by
admin on Mon Mar 31 18:18:00 GMT 2025 , Edited by admin on Mon Mar 31 18:18:00 GMT 2025
|
PRIMARY | |||
|
DB13472
Created by
admin on Mon Mar 31 18:18:00 GMT 2025 , Edited by admin on Mon Mar 31 18:18:00 GMT 2025
|
PRIMARY | |||
|
DTXSID4022866
Created by
admin on Mon Mar 31 18:18:00 GMT 2025 , Edited by admin on Mon Mar 31 18:18:00 GMT 2025
|
PRIMARY | |||
|
CHEMBL141305
Created by
admin on Mon Mar 31 18:18:00 GMT 2025 , Edited by admin on Mon Mar 31 18:18:00 GMT 2025
|
PRIMARY | |||
|
J468V64WZ1
Created by
admin on Mon Mar 31 18:18:00 GMT 2025 , Edited by admin on Mon Mar 31 18:18:00 GMT 2025
|
PRIMARY | |||
|
2898
Created by
admin on Mon Mar 31 18:18:00 GMT 2025 , Edited by admin on Mon Mar 31 18:18:00 GMT 2025
|
PRIMARY | |||
|
D003506
Created by
admin on Mon Mar 31 18:18:00 GMT 2025 , Edited by admin on Mon Mar 31 18:18:00 GMT 2025
|
PRIMARY | |||
|
100000083751
Created by
admin on Mon Mar 31 18:18:00 GMT 2025 , Edited by admin on Mon Mar 31 18:18:00 GMT 2025
|
PRIMARY | |||
|
2258
Created by
admin on Mon Mar 31 18:18:00 GMT 2025 , Edited by admin on Mon Mar 31 18:18:00 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
METABOLITE -> PARENT |
URINE
|
||
|
METABOLITE -> PARENT |
URINE
|
||
|
METABOLITE -> PARENT |
URINE
|
||
|
METABOLITE -> PARENT |
URINE
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |